TB31F
- Generic Name
- TB31F
Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali
Phase 1
Active, not recruiting
- Conditions
- Malaria,Falciparum
- Interventions
- Other: Normal saline
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 165
- Registration Number
- NCT06413108
- Locations
- 🇲🇱
Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Point G, Mali
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath